CN115109111B - Production process of progestogen - Google Patents
Production process of progestogen Download PDFInfo
- Publication number
- CN115109111B CN115109111B CN202210906447.XA CN202210906447A CN115109111B CN 115109111 B CN115109111 B CN 115109111B CN 202210906447 A CN202210906447 A CN 202210906447A CN 115109111 B CN115109111 B CN 115109111B
- Authority
- CN
- China
- Prior art keywords
- acid
- reaction
- stirring
- solution
- progestogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 20
- 239000000583 progesterone congener Substances 0.000 title claims abstract description 20
- 238000006243 chemical reaction Methods 0.000 claims abstract description 43
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 29
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims abstract description 10
- 239000003054 catalyst Substances 0.000 claims abstract description 10
- 238000005580 one pot reaction Methods 0.000 claims abstract description 10
- 238000003756 stirring Methods 0.000 claims description 30
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 25
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 23
- 239000012043 crude product Substances 0.000 claims description 19
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 18
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 16
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 14
- 239000012044 organic layer Substances 0.000 claims description 14
- 239000000047 product Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- 239000007818 Grignard reagent Substances 0.000 claims description 10
- 235000019270 ammonium chloride Nutrition 0.000 claims description 9
- 150000007524 organic acids Chemical class 0.000 claims description 9
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 8
- -1 2-methyltetrahydrofuran Grignard reagent Chemical class 0.000 claims description 7
- 238000004090 dissolution Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 239000001630 malic acid Substances 0.000 claims description 4
- 235000011090 malic acid Nutrition 0.000 claims description 4
- 239000012074 organic phase Substances 0.000 claims description 4
- 230000001376 precipitating effect Effects 0.000 claims description 2
- 239000012535 impurity Substances 0.000 abstract description 17
- 238000010511 deprotection reaction Methods 0.000 abstract description 5
- 238000002425 crystallisation Methods 0.000 abstract description 3
- 230000008025 crystallization Effects 0.000 abstract description 3
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000002904 solvent Substances 0.000 description 11
- 238000003747 Grignard reaction Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- 150000004795 grignard reagents Chemical class 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- NNQDMQVWOWCVEM-UHFFFAOYSA-N 1-bromoprop-1-ene Chemical compound CC=CBr NNQDMQVWOWCVEM-UHFFFAOYSA-N 0.000 description 3
- 229960005215 dichloroacetic acid Drugs 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- PMUPSYZVABJEKC-UHFFFAOYSA-N 1-methylcyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)C1(C)CCCCC1C(O)=O PMUPSYZVABJEKC-UHFFFAOYSA-N 0.000 description 1
- 150000000319 19-nortestosterones Chemical class 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- AEUAEICGCMSYCQ-UHFFFAOYSA-N 4-n-(7-chloroquinolin-1-ium-4-yl)-1-n,1-n-diethylpentane-1,4-diamine;dihydrogen phosphate Chemical compound OP(O)(O)=O.ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 AEUAEICGCMSYCQ-UHFFFAOYSA-N 0.000 description 1
- GJOHLWZHWQUKAU-UHFFFAOYSA-N 5-azaniumylpentan-2-yl-(6-methoxyquinolin-8-yl)azanium;dihydrogen phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.N1=CC=CC2=CC(OC)=CC(NC(C)CCCN)=C21 GJOHLWZHWQUKAU-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- VWAUPFMBXBWEQY-ANULTFPQSA-N Altrenogest Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)CC=C)C=C3)C3=C21 VWAUPFMBXBWEQY-ANULTFPQSA-N 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229960000971 altrenogest Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 229960002328 chloroquine phosphate Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010981 drying operation Methods 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- DQEUYIQDSMINEY-UHFFFAOYSA-M magnesium;prop-1-ene;bromide Chemical compound [Mg+2].[Br-].[CH2-]C=C DQEUYIQDSMINEY-UHFFFAOYSA-M 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000013386 optimize process Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229960005462 primaquine phosphate Drugs 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 1
- 150000005672 tetraenes Chemical class 0.000 description 1
- MEHHPFQKXOUFFV-OWSLCNJRSA-N trenbolone Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@H](CC3)O)C=C3)C3=C21 MEHHPFQKXOUFFV-OWSLCNJRSA-N 0.000 description 1
- 229960000312 trenbolone Drugs 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0092—Alkenyl derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Manufacturer' s | Grignard step | Crude product | Refining | Total yield of | Time period |
The scheme is provided | ------- | 83.6% | 78.7% | 65.9% | For 1-2 days |
CN106810584A | 73.5% | 57% | 70% | 29.3% | For 5-7 days |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210906447.XA CN115109111B (en) | 2022-07-29 | 2022-07-29 | Production process of progestogen |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210906447.XA CN115109111B (en) | 2022-07-29 | 2022-07-29 | Production process of progestogen |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115109111A CN115109111A (en) | 2022-09-27 |
CN115109111B true CN115109111B (en) | 2023-10-24 |
Family
ID=83334863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210906447.XA Active CN115109111B (en) | 2022-07-29 | 2022-07-29 | Production process of progestogen |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115109111B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB842676A (en) * | 1957-05-21 | 1960-07-27 | British Drug Houses Ltd | 17ª‰-hydroxy-17ª‡-alkynyl steroids of the 19-norandrostane class and method for their preparation |
CN106397519A (en) * | 2016-08-30 | 2017-02-15 | 天津市中升挑战生物科技有限公司 | Preparation method of altrenogest |
CN106810584A (en) * | 2016-12-28 | 2017-06-09 | 宁波第二激素厂 | The synthetic method of Altrenogest |
CN110256519A (en) * | 2019-05-23 | 2019-09-20 | 江苏联环药业股份有限公司 | The method of one kettle way preparation uliprista acetate |
CN110950920A (en) * | 2019-10-30 | 2020-04-03 | 浙江神洲药业有限公司 | Preparation method of tetraeestrone |
-
2022
- 2022-07-29 CN CN202210906447.XA patent/CN115109111B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB842676A (en) * | 1957-05-21 | 1960-07-27 | British Drug Houses Ltd | 17ª‰-hydroxy-17ª‡-alkynyl steroids of the 19-norandrostane class and method for their preparation |
CN106397519A (en) * | 2016-08-30 | 2017-02-15 | 天津市中升挑战生物科技有限公司 | Preparation method of altrenogest |
CN106810584A (en) * | 2016-12-28 | 2017-06-09 | 宁波第二激素厂 | The synthetic method of Altrenogest |
CN110256519A (en) * | 2019-05-23 | 2019-09-20 | 江苏联环药业股份有限公司 | The method of one kettle way preparation uliprista acetate |
CN110950920A (en) * | 2019-10-30 | 2020-04-03 | 浙江神洲药业有限公司 | Preparation method of tetraeestrone |
Non-Patent Citations (1)
Title |
---|
"孕烯醇酮衍生物的合成";刘跃金等;《沈阳化工大学学报》;第32卷(第1期);第53-55页 * |
Also Published As
Publication number | Publication date |
---|---|
CN115109111A (en) | 2022-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109776644B (en) | Synthesis method of progesterone | |
CN110563790B (en) | Method for synthesizing progesterone | |
CN114380879A (en) | Method for preparing progesterone intermediate and progesterone by using microchannel reactor | |
CN106397519A (en) | Preparation method of altrenogest | |
CN114437164A (en) | Dydrogesterone and preparation method thereof | |
CN112062802A (en) | Chenodeoxycholic acid butyl acetate extracting solution and preparation method thereof, and chenodeoxycholic acid ammonium salt and chenodeoxycholic acid preparation method | |
CN115109111B (en) | Production process of progestogen | |
CN110204585B (en) | Synthesis method of progesterone | |
CN109438538A (en) | A kind of synthetic method of -17 beta-hydroxy -3- ketone of -17 Alpha-Methyl of Stanozolol intermediate androstane | |
CA2480151A1 (en) | C-17 spirolactonization and 6,7 oxidation of steroids | |
CN109021052B (en) | Method for synthesizing lithocholic acid by taking androstenedione as raw material | |
CN114276406B (en) | Preparation method of intermediate of deoxomilpine | |
WO2023126014A1 (en) | Estrone synthesis method | |
CN112209987B (en) | Preparation method of dienogest | |
CN111057121B (en) | Recycling method and application of levonorgestrel mother liquor | |
CN105367618A (en) | Method for preparing hydrocortisone | |
CN106977569A (en) | The preparation method of the α hydroxyprogesterone acetates of 6 methylene 17 | |
US2326756A (en) | Ketones of the cyclopentano-poly-hydrophenanthrene series and a method of producing the same | |
EP1841778A1 (en) | Method for preparing medrogestone | |
US3248408A (en) | Purification of steroid phosphates | |
CN110746477B (en) | Total synthesis preparation method of estrone | |
CN107011403A (en) | A kind of preparation method for improving cholesterol purity | |
CN112409432B (en) | Synthesis method of exemestane | |
CN115322239B (en) | Method for recovering diketone from mandipropamid carbon loss ester mother liquor | |
CN114437163B (en) | Method for preparing rocuronium bromide intermediate 17-acetoxy-5 alpha-androstane-2, 16-diene by one-pot method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Cui Zhigang Inventor after: Zhang Lei Inventor after: Yu Guiju Inventor after: Yang Xue Inventor after: Zhao Jian Inventor after: Yang Xiaojun Inventor after: Pan Xueqing Inventor after: Zhang Yongzan Inventor after: Zhu Shijiang Inventor after: Wang Jian Inventor after: Liu Haiyu Inventor after: Han Yi Inventor after: Chen Mingxia Inventor after: Liu Ziwei Inventor after: Luo Xiao Inventor before: Cui Zhigang Inventor before: Zhang Lei Inventor before: Yu Guiju Inventor before: Yang Xue Inventor before: Zhao Jian Inventor before: Yang Xiaojun Inventor before: Pan Xueqing Inventor before: Zhang Yongzan Inventor before: Zhu Shijiang Inventor before: Wang Jian Inventor before: Liu Haiyu Inventor before: Han Yi Inventor before: Chen Mingxia Inventor before: Liu Ziwei Inventor before: Luo Xiao |
|
GR01 | Patent grant | ||
GR01 | Patent grant |